MCRB icon

Seres Therapeutics

93 hedge funds and large institutions have $50M invested in Seres Therapeutics in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 25 increasing their positions, 27 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

22% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 27

25% less capital invested

Capital invested by funds: $66.8M → $50M (-$16.7M)

33% less call options, than puts

Call options by funds: $319K | Put options by funds: $478K

Holders
93
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$319K
Puts
$478K
Net Calls
Net Calls Change

Top Buyers

1 +$1.09M
2 +$574K
3 +$543K
4
Jane Street
Jane Street
New York
+$449K
5
Verition Fund Management
Verition Fund Management
Connecticut
+$227K

Top Sellers

1 -$3.66M
2 -$3.2M
3 -$1.58M
4
State Street
State Street
Massachusetts
-$1.16M
5
Bank of America
Bank of America
North Carolina
-$1.12M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$16.7M
2
$16.4M
3
$4.55M
4
$1.74M
5
$1.29M
6
$1.28M
7
$1.03M
8
$821K
9
$727K
10
$522K
11
$512K
12
$483K
13
$381K
14
$303K
15
$247K
16
$246K
17
$227K
18
$212K
19
$194K
20
$145K
21
$136K
22
$124K
23
$102K
24
$92.4K
25
$89.5K